| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8312571 | Clinica Chimica Acta | 2014 | 9 Pages |
Abstract
The framework aims to support the understanding of key stakeholders. The laboratory profession needs to strengthen collaboration with industry and experts in evidence-based medicine, regulatory bodies and policy makers for better decisions about the use of new and existing medical tests.
Keywords
High sensitivity cardiac troponinPOCThs-cTncTnIFCCIVDCK-MBNGSPHbA1cRCTINRFDABNPACRNHSACSAmIRandomized controlled trialEuropean UnionClinical effectivenessNational Glycohemoglobin Standardization ProgramBiomarkerCardiac troponinIn vitro diagnosticsNICEFood and Drug AdministrationConformité EuropéenneAcute coronary syndromeAcute myocardial infarctionInternational Federation of Clinical Chemistry and Laboratory MedicineNational Institute for Health and Care ExcellenceInternational Normalized RatioPoint of care testingHemoglobin A1cC-reactive proteinCRPEvidence-based laboratory medicineB-type natriuretic peptide
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Andrea R. Horvath, Sarah J. Lord, Andrew StJohn, Sverre Sandberg, Christa M. Cobbaert, Stefan Lorenz, Phillip J. Monaghan, Wilma D.J. Verhagen-Kamerbeek, Christoph Ebert, Patrick M.M. Bossuyt,